Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Feb 14 2002
Washington, D.C. (February 14, 2002) - The Biotechnology Industry Organization (BIO) today announced the names of industry leaders who will participate in the...
Feb 13 2002
Washington, D.C. (February 13, 2002) – The Biotechnology Industry Organization (BIO) today announced that Dr. Harold Varmus, recipient of the Nobel Prize...
Feb 12 2002
Washington, D.C. (February 12, 2002) - Christopher Reeve, the actor, director and patients’ rights advocate, will participate in a panel discussion on...
Feb 8 2002
WASHINGTON, D.C. – (February 8, 2002) – Biotechnology Industry Organization President Carl B. Feldbaum described the $272 million in user fees...
Feb 5 2002
Washington, D.C. (February 5, 2002)- The Biotechnology Industry Organization (BIO) today announced the names of the biotechnology companies selected to present...
Feb 4 2002
Washington, D.C. (February 4, 2002) – The FDA approved 16 new biotechnology-based medicines and vaccines in 2001, as well as eight new indications for...
Jan 30 2002
WASHINGTON, DC – (January 30, 2002) – Advance media registration for the 16th annual BIO 2002 International Convention and Exhibition is now available. The...
Jan 18 2002
WASHINGTON, D.C. - (January 18, 2002) - Biotechnology Industry Organization Vice President for Bioethics Michael Werner released the following statement on the...
Dec 19 2001
Washington, D.C. (December 19, 2001) – The Centers for Medicare and Medicaid Services Wednesday postponed by at least three months implementation of a...


Biotechnology News

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...

September 19, 2014

JACKSONVILLE, Fla.--(BUSINESS WIRE)--AACE publishes its "Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease," including an algorithm and therapeutic...

September 19, 2014

JACKSONVILE, Fla.--(BUSINESS WIRE)--AACE plans to address issues with quality, safety, access, and post- marketing surveillance of optimal glucose monitoring for glucose...